Literature DB >> 2495142

Experiences in the surgical treatment of cranio-orbital neurofibromatosis.

M D Poole1.   

Abstract

Experience with surgical management of cranio-orbital neurofibromatosis in 11 patients is reported. The surgery has a relatively high complication rate compared with craniofacial procedures for other conditions. The presence of an eye which is to be preserved in the orbit introduces difficulties in producing improved appearance without compromising corneal cover. A two-stage approach is recommended when an eye is present. The cosmetic improvements have been disappointing to the surgical team but generally worthwhile to the patients and their families.

Entities:  

Mesh:

Year:  1989        PMID: 2495142     DOI: 10.1016/0007-1226(89)90197-5

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  5 in total

1.  Labial neurofibroma as the presenting feature of genital and orbitotemporal neurofibromatosis.

Authors:  Deep Dutta; Ajitesh Roy; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  Indian J Pediatr       Date:  2013-12-29       Impact factor: 1.967

2.  Transcranial surgery through pterional approach for removal of cranio-orbital tumors by an interdisciplinary team of nurosurgeons and ophthalmologists.

Authors:  Yan Liu; Jiang-Rong Ma; Xue-Liang Xu
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

3.  Reconstruction of Sphenoid Wing Dysplasia with Pulsating Exophthalmos in a Case of Neurofibromatosis Type 1 Supported by Intraoperative Navigation Using a New Skull Reference System.

Authors:  Reinhard E Friedrich; Max Heiland; Uwe Kehler; Rainer Schmelzle
Journal:  Skull Base       Date:  2003-11

4.  Clinical experience of surgically treating giant neurofibromatosis-1.

Authors:  Baoguo Chen; Minghuo Xu; Huifeng Song; Quanwen Gao
Journal:  Int Wound J       Date:  2016-04-12       Impact factor: 3.315

5.  Orbitotemporal neurofibromatosis: case report.

Authors:  Mahalakshmi Balasubramanyam; Goutham Cugati; Bipasha Mukherjee
Journal:  Case Rep Ophthalmol Med       Date:  2012-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.